The U.S. Food and Drug Administration (FDA) and the Medicines and Healthcare products Regulatory Agency have approved Eli Lilly and Company's Zepbound (Mounjaro) (tirzepatide) injection
Stanley Capital Partners announces its portfolio company, Laboratoire X.O, has completed the acquisition of the prescription drug Nimodipine under the brand name Nimotop from Bayer for several markets globally excluding mainland China.
Medicann, the award winning medicinal cannabis clinic is launching the first clinic in Ireland, and are now accepting patients who wish to know if they are eligible for treatment.
Egis Pharmaceuticals is expanding its usual activities with new elements thanks to investments exceeding a total value of more than 100 billion HUF in Hungary over the past period.
Sirio Pharma Co has announced the addition of new gummy manufacturing capabilities at its Best Formulations site, the company's manufacturing facility in the United States.
Helping to make pharmaceutical manufacturing compliant, safer, and faster, tech startup Leucine is today announcing a $7M series A funding round led by Ecolab Inc., a strategic investor, to scale its Compliance Cloud platform globally.
The first legal medical cannabis factory on the island of Ireland is on course to start production in 2024. Growth Industries Pharma Ltd has been able to push ahead with its construction of a facility to grow medical cannabis.
Navin Fluorine International Ltd, part of the Padmanabh Mafatlal Group, has unveiled the new identity for its contract development and manufacturing division, Navin Molecular.
Pharmacierge, the leader in private e-prescription app and delivery services announces its forthcoming expansion within the heart of London’s healthcare district.
Ypsomed has concluded a long-term supply agreement with Novo Nordisk for large quantities of autoinjectors. The autoinjectors will be used to administer drugs for the self-treatment in various metabolic indications.
